Samsara BioCapital
Overview
Samsara BioCapital is a life sciences investment firm that focuses on translating cutting-edge biology into new therapies to treat patients with unmet medical needs across all stages of public and private companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Principia | Aug 2018 | Series C | Lead |
| Parabilis Medicines | Jan 2026 | Series F | Co-investor |
| Fog Pharmaceuticals | Jan 2026 | Series F | Co-investor |
| Recursion Pharmaceuticals | Sep 2020 | Series D | Co-investor |
| Alumis Inc | Mar 2024 | Series C | Lead |
For institutional investors. Book with your work email.
Key People
Alan Eisenberg
Venture Partner
Betsy Santos
Venture Partner and Chief People Officer, Chief People Officer
Dan Spiegelman
Venture Partner
Dolca Thomas
Venture Partner Senior Advisor
Eric Dobmeier
Venture Partner
Gunaretnam Rajagopal
Venture Partner
James Edwards
Venture Partner, Samsara BioCaptial
John Orwin
Venture Partner
Robert Baffi
Venture Partner
Stephen Shuttleworth
Venture Partner
Cory Freedland
Partner
Tom Bumol
Member, Board Of Directors
Abraham Bassan
Principal
Mitchell Mutz
Senior Principal
Ehi Akhirome
Investor
Matt Eckler
Healthcare Investor
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Samsara BioCapital based?
Samsara BioCapital is headquartered in Palo Alto, California, United States.
When was Samsara BioCapital founded?
Samsara BioCapital was founded in 2016.
How many portfolio companies does Samsara BioCapital have?
Samsara BioCapital has 72 portfolio companies in Caplight's dataset.
What are some companies in Samsara BioCapital's portfolio?
Portfolio companies visible on Caplight include Principia, Parabilis Medicines, Fog Pharmaceuticals, Recursion Pharmaceuticals, Alumis Inc.
What was Samsara BioCapital's most recent investment shown here?
Samsara BioCapital's most recent investment in this portfolio sample was in Parabilis Medicines in 2026.
What sectors does Samsara BioCapital focus on?
Samsara BioCapital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Enterprise Software, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech.
What company stages does Samsara BioCapital focus on?
Samsara BioCapital typically invests at the MultiStage stage.
What is Samsara BioCapital's AUM?
Samsara BioCapital's assets under management are estimated between $1.0B and $10.0B.